tiprankstipranks
Advertisement
Advertisement

OTLK Stock Latest News

Outlook Therapeutics Announces CFO Transition and Board Change
Company AnnouncementsOutlook Therapeutics Announces CFO Transition and Board Change
14h ago
8K
OTLK
Outlook CFO Lawrence Kenyon to step down, Kevin Lundquist to succeed
PremiumThe Fly
Outlook CFO Lawrence Kenyon to step down, Kevin Lundquist to succeed
14h ago
CV
OTLK
Outlook Therapeutics Earnings Call: LYTENAVA Faces Test
PremiumCompany Announcements
Outlook Therapeutics Earnings Call: LYTENAVA Faces Test
3d ago
OTLK
Outlook Therapeutics delays quarterly SEC filing
PremiumCompany Announcements
Outlook Therapeutics delays quarterly SEC filing
10d ago
OTLK
Outlook Therapeutics: Buy Rating Reiterated as LYTENAVA Launch Strategy Supports Unchanged $4 Price Target
PremiumRatings
Outlook Therapeutics: Buy Rating Reiterated as LYTENAVA Launch Strategy Supports Unchanged $4 Price Target
11d ago
OTLK
Outlook Therapeutics announces common stock, warrants offering
PremiumThe FlyOutlook Therapeutics announces common stock, warrants offering
11d ago
OTLK
Outlook Therapeutics $100M Spot Secondary re-offered at 99c
Premium
The Fly
Outlook Therapeutics $100M Spot Secondary re-offered at 99c
11d ago
OTLK
Outlook Therapeutics 55.6M share Spot Secondary priced at 99c
Premium
The Fly
Outlook Therapeutics 55.6M share Spot Secondary priced at 99c
11d ago
OTLK
Outlook Therapeutics reports Q3 EPS (15c), consensus (8c)
PremiumThe Fly
Outlook Therapeutics reports Q3 EPS (15c), consensus (8c)
12d ago
OTLK
Morning Movers: Applied Materials slips after quarterly earnings
PremiumThe Fly
Morning Movers: Applied Materials slips after quarterly earnings
12d ago
W
FOX
Outlook Therapeutics Announces $55 Million Equity Offering
PremiumCompany Announcements
Outlook Therapeutics Announces $55 Million Equity Offering
14d ago
8K
OTLK
Options Volatility and Implied Earnings Moves Today, August 14, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, August 14, 2026
14d ago
DGXX
HIVE
Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks
PremiumCompany AnnouncementsOutlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks
16d ago
8K
OTLK
Is OTLK a Buy, Before Earnings?
Premium
Pre-Earnings
Is OTLK a Buy, Before Earnings?
16d ago
OTLK
The Week That Was, The Week Ahead: Macro and Markets, August 9
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, August 9
19d ago
F
V
Darden, Outlook, Boyd, Garmin, Scotts: Insider Trade Shock
PremiumWeekend Updates
Darden, Outlook, Boyd, Garmin, Scotts: Insider Trade Shock
27d ago
BYD
DRI
OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
PremiumWeekend Updates
OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
27d ago
CAPR
CORT
Outlook Therapeutics price target raised to $1.60 from 50c at H.C. Wainwright
PremiumThe Fly
Outlook Therapeutics price target raised to $1.60 from 50c at H.C. Wainwright
1M ago
OTLK
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
PremiumThe Fly
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
1M ago
OTLK
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
PremiumThe FlyOutlook Therapeutics upgraded to Buy from Neutral at BTIG
1M ago
OTLK
Outlook Therapeutics Gains FDA Approval for LYTENAVA Launch
Premium
Company Announcements
Outlook Therapeutics Gains FDA Approval for LYTENAVA Launch
1M ago
8K
OTLK
Outlook Therapeutics Inc trading resumes
Premium
The Fly
Outlook Therapeutics Inc trading resumes
1M ago
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >